QGEN Nov 2024 55.000 call
| Previous close | 0.7400 |
| Open | 0.9100 |
| Bid | 0.6000 |
| Ask | 0.8000 |
| Strike | 55.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.7400 - 0.9100 |
| Contract range | N/A |
| Volume | |
| Open interest | 368 |
Globe NewswireQIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe
New QIAcuity digital PCR Custom Assay Design Tool for copy number variation analysis supports researchers’ customization needs, complementing QIAGEN’s existing pre-designed assays // GeneGlobe Design and Analysis Hub receives further enhancements, improving user experience and capabilities to design panels collaboratively // Advancements strengthen QIAGEN as a trusted partner for researchers, catering to their diverse needs to further accelerate drug discovery and other applicationsVenlo, the Ne
ZacksWhy Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Rocket Pharmaceuticals (RCKT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksQIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
QIAGEN's (QGEN) new QIAstat-Dx Gastrointestinal Panel 2 offers fast and accurate identification of up to 16 common gastrointestinal pathogens.
